Upgrades:
Caterpillar, Inc. (NYSE:CAT) was upgraded by stock analysts
at UBS AG from a “neutral” rating to a “buy” rating in a research report issued
on Monday. Other analysts have also issued reports about the stock. Wells Fargo
& Company reaffirmed an “outperform” rating on shares of Caterpillar in a
research report on Wednesday, July 26th. Vetr raised shares of Caterpillar from
a “strong sell” rating to a “buy” rating and set a $120.03 price target on the
stock in a research report on Thursday, August 10th. Read more …
BP p.l.c. (NYSE:BP) was upgraded by equities research
analysts at BMO Capital Markets from a “market perform” rating to an
“outperform” rating in a note issued to investors on Monday. Several other
analysts have also issued reports on BP. BidaskClub raised shares of BP p.l.c.
from a “strong sell” rating to a “sell” rating in a research report on
Thursday, August 3rd. TheStreet lowered shares of BP p.l.c. from a “b-” rating
to a “c” rating in a research report on Thursday, August 10th. Read more …
Gap, Inc. (The) (NYSE:GPS) was upgraded by analysts at
Credit Suisse Group from an “underperform” rating to a “neutral” rating in a
research note issued on Tuesday, MarketBeat reports. The firm currently has a
$30.00 target price on the apparel retailer’s stock, up from their prior target
price of $23.00. Credit Suisse Group’s target price would suggest a potential
upside of 7.37% from the company’s current price. Read more …
Morgan Stanley upgraded shares of Pfizer, Inc. (NYSE:PFE)
from an equal weight rating to an overweight rating in a report published on
Wednesday morning. They currently have $39.00 target price on the
biopharmaceutical company’s stock, up from their prior target price of $35.00. Other
equities research analysts have also issued reports about the stock. Jefferies
Group LLC set a $35.00 price target on shares of Pfizer and gave the company a
neutral rating in a report on Wednesday, August 2nd. Read more …
Dover Corporation (NYSE:DOV) was upgraded by investment
analysts at J P Morgan Chase & Co from a “neutral” rating to an
“overweight” rating in a research report issued to clients and investors on
Wednesday, MarketBeat.com reports. The brokerage presently has a $105.00 price
target on the industrial products company’s stock, up from their prior price
target of $80.00. J P Morgan Chase & Co’s target price points to a
potential upside of 13.78% from the stock’s previous close. Read more …
Leggett & Platt, Incorporated (NYSE:LEG) was upgraded by
investment analysts at SunTrust Banks, Inc. from a “hold” rating to a “buy”
rating in a research note issued on Friday, The Fly reports. The analysts noted
that the move was a valuation call. A number of other equities analysts have
also recently weighed in on LEG. Piper Jaffray Companies initiated coverage on
Leggett & Platt, in a report on Monday, June 5th. They issued an
“overweight” rating and a $59.00 price target for the company. Read more …
Astrazeneca PLC (NYSE:AZN) was upgraded by research analysts
at Sanford C. Bernstein from a “market perform” rating to an “outperform”
rating in a note issued to investors on Friday, The Fly reports. AZN has been
the topic of a number of other research reports. Piper Jaffray Companies
reaffirmed a “buy” rating on shares of Astrazeneca PLC in a research report on
Wednesday, August 9th. BidaskClub lowered Astrazeneca PLC from a “hold” rating
to a “sell” rating in a research report on Monday, July 24th. Read more …
Downgrades:
Kellogg Company (NYSE:K) was downgraded by investment
analysts at Piper Jaffray Companies from an “overweight” rating to a “neutral”
rating in a research report issued to clients and investors on Tuesday,
MarketBeat reports. They currently have a $78.00 target price on the stock.
Piper Jaffray Companies’ price target would suggest a potential upside of
18.42% from the company’s previous close. The analysts wrote, “real threat” to
food companies. The firm’s Michael Lavery downgraded Kellogg’s stock rating
from Overweight to Neutral with a price target slashed from $78 to $72. Read more …
Wells Fargo & Company lowered shares of Under Armour,
Inc. (NYSE:UAA) from a market perform rating to an underperform rating in a
research report published on Tuesday morning. They currently have $13.00 price
target on the stock, down from their prior price target of $17.00. Other
equities analysts also recently issued reports about the company. Vetr
downgraded Under Armour from a strong-buy rating to a hold rating and set a
$21.02 price objective for the company. in a research report on Monday, July
17th. Read more …
J P Morgan Chase & Co cut shares of 3M Company
(NYSE:MMM) from a neutral rating to an underweight rating in a research report
sent to investors on Wednesday morning. They currently have $201.00 target
price on the conglomerate’s stock, up from their previous target price of
$185.00. A number of other equities analysts have also recently issued reports
on the company. Royal Bank of Canada reiterated a hold rating and set a $209.00
target price on shares of 3M in a report on Friday, September 15th. Read more …
Hanesbrands Inc. (NYSE:HBI) was downgraded by investment
analysts at Instinet from a “buy” rating to a “neutral” rating in a report
released on Thursday, Marketbeat reports. They presently have a $26.00 price
objective on the textile maker’s stock. Instinet’s target price would indicate
a potential upside of 5.52% from the stock’s current price. Several other
analysts also recently weighed in on HBI. BidaskClub upgraded Hanesbrands from
a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th.
Read more …
BofA Merrill has downgraded Ventas (NYSE:VTR) from Buy to Neutral in a report released on 9/22/2017. Yesterday Ventas (NYSE:VTR) traded -1.14% lower at $67.52.
The company’s 50-day moving average is $67.37 and its 200-day moving average is
$66.32. The last closing price is up 0.64% from the 200-day moving average,
compared to the S&P 500 which has increased 0.04% over the same time.
312,552 shares of the stock were exchanged, down from an average trading volume
of 1,470,620. Read more …
BofA Merrill has downgraded HCP (NYSE:HCP) from Buy to
Neutral in a statement released on 9/22/2017. Having a price of $28.57, HCP
(NYSE:HCP) traded -1.19% lower on the day. The last stock close price is down
-8.89% from the 200-day moving average, compared to the S&P 500 which has
increased 0.04% over the same time. The company has recorded a 50-day moving
average of $29.61 and a 200-day moving average of $30.98. 591,576 shares of the
stock were exchanged, down from an average trading volume of 3,372,000. Read more …
No comments:
Post a Comment